GPR120 activators (Caldan)

N/A

Report date: 2025/01/26 18:29:32
NME

Base Information

Drug NameGPR120 activators (Caldan)
Drug Alias NameGPR120 activators (Caldan)free fatty acid receptor 4 activators (Caldan)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 4 agonists
TargetsFree fatty acid receptor 4
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaldan Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCaldan Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A